ENO2 and ovarian cancer: As summarized in Table 2, no significant correlations were detected between the expression level of CEP55 protein and patient age, histological type, and serum CA125, CA199, NSE, CEA, β-HCG, or CA724 expression levels in patients with ovarian cancer.